| (210) | Number of the EPO application | 17705706 |
| (220) | Filing date of the EPO application | 2017.02.01 |
| (80) | EPO patent specification publication (B) | EPB nr. 47/2021, 2021.11.24 |
| (110) | EPO patent number | 3411358 |
| (21) | Number of the application | e 2018 1184 |
| (71) | Name(s) of applicant(s), code of the country | Takeda Pharmaceutical Company Limited, JP; |
| (72) | Name(s) of inventor(s), code of the country | FUJIMOTO Tatsuhiko, JP;
RIKIMARU Kentaro, JP;
FUKUDA Koichiro, JP;
SUGIMOTO Hiromichi, JP;
MATSUMOTO Takahiro, JP;
TOKUNAGA Norihito, JP;
HIROZANE Mariko, JP; |
| (73) | Name(s) of owner(s), code of the country | TAKEDA Pharmaceutical Company Limited, JP; |
| (54) | Title of the invention | SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 211/36 (2006.01.01); C07D 211/24 (2006.01.01); C07D 211/56 (2006.01.01); C07D 401/06 (2006.01.01); C07D 401/12 (2006.01.01); C07D 401/14 (2006.01.01); C07D 405/06 (2006.01.01); C07D 405/12 (2006.01.01); C07D 405/14 (2006.01.01); C07D 409/06 (2006.01.01); C07D 409/12 (2006.01.01); C07D 413/06 (2006.01.01); C07D 417/06 (2006.01.01); C07D 417/14 (2006.01.01); A61K 31/435 (2006.01.01); A61P 3/04 (2006.01.01) |
| (19) | Country | JP |
| (41) | Date of publication of the application | 2019.01.31 |
| (30) | Priority | 2016019834, 2016.02.04, JP |
| (86) | International application | PCT/JP2017/003610, 2017.02.01 |
| (87) | International publication | WO 2017/135306, 2017.08.10 |